{"nct_id":"NCT03564691","title":"Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4830-001)","status":"COMPLETED","status_verified_date":"2025-10","start_date":"2018-07-11","start_date_type":"ACTUAL","primary_completion_date":"2025-09-26","primary_completion_date_type":"ACTUAL","completion_date":"2025-09-26","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}